Cargando…

Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus

Although hepatitis C virus (HCV) infection is very common, identification of patients during acute infection is rare. Consequently, little is known about the immune response during this critical stage of the disease. We analyzed the T lymphocyte response during and after acute resolving HCV infectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Lechner, Franziska, Wong, David K.H., Dunbar, P. Rod, Chapman, Roger, Chung, Raymond T., Dohrenwend, Paul, Robbins, Gregory, Phillips, Rodney, Klenerman, Paul, Walker, Bruce D.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213430/
https://www.ncbi.nlm.nih.gov/pubmed/10790425
_version_ 1782148893067182080
author Lechner, Franziska
Wong, David K.H.
Dunbar, P. Rod
Chapman, Roger
Chung, Raymond T.
Dohrenwend, Paul
Robbins, Gregory
Phillips, Rodney
Klenerman, Paul
Walker, Bruce D.
author_facet Lechner, Franziska
Wong, David K.H.
Dunbar, P. Rod
Chapman, Roger
Chung, Raymond T.
Dohrenwend, Paul
Robbins, Gregory
Phillips, Rodney
Klenerman, Paul
Walker, Bruce D.
author_sort Lechner, Franziska
collection PubMed
description Although hepatitis C virus (HCV) infection is very common, identification of patients during acute infection is rare. Consequently, little is known about the immune response during this critical stage of the disease. We analyzed the T lymphocyte response during and after acute resolving HCV infection in three persons, using interferon (IFN)-γ enzyme-linked immunospot (ELISPOT) and human histocompatibility leukocyte antigen (HLA) peptide tetramer assays. Acute infection was associated with a broadly directed T helper and cytotoxic T lymphocyte (CTL) response, which persisted after resolution of clinical hepatitis and clearance of viremia. At the earliest time point studied, highly activated CTL populations were observed that temporarily failed to secrete IFN-γ, a “stunned” phenotype, from which they recovered as viremia declined. In long-term HCV-seropositive persons, CTL responses were more common in persons who had cleared viremia compared with those with persistent viremia, although the frequencies of HCV-specific CTLs were lower than those found in persons during and after resolution of acute HCV infection. These studies demonstrate a strong and persistent CTL response in resolving acute HCV infection, and provide rationale to explore immune augmentation as a therapeutic intervention in chronic HCV infection.
format Text
id pubmed-2213430
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-22134302008-04-16 Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus Lechner, Franziska Wong, David K.H. Dunbar, P. Rod Chapman, Roger Chung, Raymond T. Dohrenwend, Paul Robbins, Gregory Phillips, Rodney Klenerman, Paul Walker, Bruce D. J Exp Med Original Article Although hepatitis C virus (HCV) infection is very common, identification of patients during acute infection is rare. Consequently, little is known about the immune response during this critical stage of the disease. We analyzed the T lymphocyte response during and after acute resolving HCV infection in three persons, using interferon (IFN)-γ enzyme-linked immunospot (ELISPOT) and human histocompatibility leukocyte antigen (HLA) peptide tetramer assays. Acute infection was associated with a broadly directed T helper and cytotoxic T lymphocyte (CTL) response, which persisted after resolution of clinical hepatitis and clearance of viremia. At the earliest time point studied, highly activated CTL populations were observed that temporarily failed to secrete IFN-γ, a “stunned” phenotype, from which they recovered as viremia declined. In long-term HCV-seropositive persons, CTL responses were more common in persons who had cleared viremia compared with those with persistent viremia, although the frequencies of HCV-specific CTLs were lower than those found in persons during and after resolution of acute HCV infection. These studies demonstrate a strong and persistent CTL response in resolving acute HCV infection, and provide rationale to explore immune augmentation as a therapeutic intervention in chronic HCV infection. The Rockefeller University Press 2000-05-01 /pmc/articles/PMC2213430/ /pubmed/10790425 Text en © 2000 The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Original Article
Lechner, Franziska
Wong, David K.H.
Dunbar, P. Rod
Chapman, Roger
Chung, Raymond T.
Dohrenwend, Paul
Robbins, Gregory
Phillips, Rodney
Klenerman, Paul
Walker, Bruce D.
Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
title Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
title_full Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
title_fullStr Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
title_full_unstemmed Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
title_short Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
title_sort analysis of successful immune responses in persons infected with hepatitis c virus
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213430/
https://www.ncbi.nlm.nih.gov/pubmed/10790425
work_keys_str_mv AT lechnerfranziska analysisofsuccessfulimmuneresponsesinpersonsinfectedwithhepatitiscvirus
AT wongdavidkh analysisofsuccessfulimmuneresponsesinpersonsinfectedwithhepatitiscvirus
AT dunbarprod analysisofsuccessfulimmuneresponsesinpersonsinfectedwithhepatitiscvirus
AT chapmanroger analysisofsuccessfulimmuneresponsesinpersonsinfectedwithhepatitiscvirus
AT chungraymondt analysisofsuccessfulimmuneresponsesinpersonsinfectedwithhepatitiscvirus
AT dohrenwendpaul analysisofsuccessfulimmuneresponsesinpersonsinfectedwithhepatitiscvirus
AT robbinsgregory analysisofsuccessfulimmuneresponsesinpersonsinfectedwithhepatitiscvirus
AT phillipsrodney analysisofsuccessfulimmuneresponsesinpersonsinfectedwithhepatitiscvirus
AT klenermanpaul analysisofsuccessfulimmuneresponsesinpersonsinfectedwithhepatitiscvirus
AT walkerbruced analysisofsuccessfulimmuneresponsesinpersonsinfectedwithhepatitiscvirus